X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35) 35
index medicus (33) 33
acting neuraminidase inhibitor (29) 29
pharmacology & pharmacy (23) 23
animals (18) 18
antiviral agents - pharmacology (18) 18
laninamivir (16) 16
oseltamivir (16) 16
zanamivir - analogs & derivatives (16) 16
influenza (15) 15
influenza, human - drug therapy (15) 15
neuraminidase - antagonists & inhibitors (15) 15
antiviral agents - therapeutic use (13) 13
female (12) 12
antiviral agents (11) 11
infectious diseases (10) 10
male (10) 10
virology (10) 10
zanamivir (10) 10
antiviral agents - chemistry (9) 9
child (9) 9
zanamivir - pharmacology (9) 9
cs-8958 (8) 8
in-vitro (8) 8
influenza, human - virology (8) 8
mice (8) 8
administration, inhalation (7) 7
double-blind (7) 7
efficacy (7) 7
health aspects (7) 7
long-acting neuraminidase inhibitor (7) 7
zanamivir - administration & dosage (7) 7
chemistry, medicinal (6) 6
neuraminidase inhibitor (6) 6
sialidase fusion protein (6) 6
zanamivir - therapeutic use (6) 6
adult (5) 5
cell line (5) 5
drug therapy (5) 5
enzyme inhibitors - administration & dosage (5) 5
hematology, oncology and palliative medicine (5) 5
influenza a virus, h3n2 subtype - drug effects (5) 5
influenza, human - epidemiology (5) 5
laninamivir octanoate (5) 5
mice, inbred balb c (5) 5
neuraminidase - metabolism (5) 5
neuraminidase inhibitors (5) 5
orthomyxoviridae - drug effects (5) 5
prodrug (5) 5
proteins (5) 5
virus diseases - drug therapy (5) 5
viruses (5) 5
zanamivir - pharmacokinetics (5) 5
adolescent (4) 4
amino acid sequence (4) 4
antiviral agents - administration & dosage (4) 4
dogs (4) 4
enzyme inhibitors - chemistry (4) 4
enzyme inhibitors - pharmacology (4) 4
influenza a virus - drug effects (4) 4
influenza a virus, h1n1 subtype - drug effects (4) 4
inhibitory concentration 50 (4) 4
microbial sensitivity tests (4) 4
microbiology (4) 4
models, molecular (4) 4
molecular sequence data (4) 4
neuraminidase (4) 4
orthomyxoviridae infections - drug therapy (4) 4
peramivir (4) 4
pharmacokinetics (4) 4
prodrugs - pharmacokinetics (4) 4
research (4) 4
single (4) 4
2009 h1n1 influenza (3) 3
administration, intranasal (3) 3
aged (3) 3
antiviral agents - chemical synthesis (3) 3
antiviral agents - pharmacokinetics (3) 3
antivirals (3) 3
binding sites (3) 3
chemistry, organic (3) 3
child, preschool (3) 3
critically-ill patients (3) 3
dosage and administration (3) 3
drug discovery - trends (3) 3
drug resistance, viral (3) 3
drug resistance, viral - drug effects (3) 3
drugs (3) 3
enzyme inhibitors - pharmacokinetics (3) 3
enzyme inhibitors - therapeutic use (3) 3
ic50 (3) 3
infection (3) 3
influenza a virus, h3n2 subtype - isolation & purification (3) 3
inhibitor (3) 3
medicine & public health (3) 3
medicine, research & experimental (3) 3
middle aged (3) 3
orthomyxoviridae infections - virology (3) 3
oseltamivir - pharmacology (3) 3
oxidation-reduction (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Baycrest Hospital - Course Reserves (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Course Reserves (1) 1
Gerstein Science - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Reference (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Reference (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
Women's College Hospital - Pharmacy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert Review of Anti-infective Therapy, ISSN 1478-7210, 10/2011, Volume 9, Issue 10, pp. 851 - 857
Oseltamivir and zanamivir are well-established and well-researched drugs for the treatment of influenza in Japan and the rest of the world. A new neuraminidase... 
influenza | neuraminidase inhibitor | inhale | single administration | laninamivir | long acting | MULTICENTER | SINGLE | EFFICACY | SAFETY | OSELTAMIVIR | PRODRUG | DOUBLE-BLIND | CS-8958 | PHARMACOLOGY & PHARMACY | Influenza A Virus, H5N1 Subtype - enzymology | Prodrugs - administration & dosage | Antiviral Agents - pharmacokinetics | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Influenza in Birds - prevention & control | Influenza in Birds - immunology | Caprylates - metabolism | Viral Proteins - metabolism | Enzyme Inhibitors - administration & dosage | Zanamivir - analogs & derivatives | Zanamivir - pharmacokinetics | Adult | Influenza in Birds - drug therapy | Influenza, Human - virology | Influenza B virus - drug effects | Influenza, Human - drug therapy | Child | Virus Replication - drug effects | Influenza A Virus, H3N2 Subtype - enzymology | Antiviral Agents - therapeutic use | Japan | Administration, Inhalation | Neuraminidase - metabolism | Birds | Viral Proteins - antagonists & inhibitors | Influenza A Virus, H5N1 Subtype - drug effects | Influenza A Virus, H1N1 Subtype - drug effects | Influenza B virus - physiology | Antiviral Agents - administration & dosage | Caprylates - chemistry | Enzyme Inhibitors - therapeutic use | Zanamivir - therapeutic use | Animals | Prodrugs - pharmacokinetics | Influenza A Virus, H1N1 Subtype - enzymology | Oseltamivir - administration & dosage | Influenza in Birds - virology | Zanamivir - administration & dosage | Drug Resistance, Viral - drug effects | Neuraminidase - antagonists & inhibitors | Prodrugs - therapeutic use | Influenza, Human - prevention & control | Influenza, Human - immunology | Usage | Oseltamivir phosphate | Drug therapy | Health aspects | Patient outcomes | Influenza
Journal Article
Journal Article
INFLUENZA AND OTHER RESPIRATORY VIRUSES, ISSN 1750-2640, 05/2011, Volume 5, pp. 93 - 95
We speculate that there are two unique characteristics that explain the long action of CS-8958: one is a stable binding of its active metabolite laninamivir to... 
neuraminidase inhibitor | INFECTIOUS DISEASES | VIROLOGY | laninamivir | mechanism | long-acting | Inavir (R)
Journal Article
JOURNAL OF BIOMEDICAL SCIENCE, ISSN 1021-7770, 10/2019, Volume 26, Issue 1, pp. 1 - 20
Influenza is a long-standing health problem. For treatment of seasonal flu and possible pandemic infections, there is a need to develop new anti-influenza... 
Drug | ANTIVIRAL AGENTS | MEDICINE, RESEARCH & EXPERIMENTAL | Conjugate | PHOTODYNAMIC THERAPY | ZANAMIVIR | Congener | INFLUENZA-VIRUS NEURAMINIDASE | SIALIC-ACID | CLINICAL PHARMACOKINETICS | CELL BIOLOGY | PHOSPHONIC-ACID ANALOGS | Influenza | Neuraminidase | Inhibitor | HIGHLY POTENT | ACTING NEURAMINIDASE INHIBITOR | OSELTAMIVIR CARBOXYLATE
Journal Article
Journal Article
Journal of Infection and Chemotherapy, ISSN 1341-321X, 08/2019, Volume 25, Issue 8, pp. 584 - 588
Four neuraminidase (NA) inhibitors and an RNA synthesis inhibitor were recently approved and are currently in clinical use for influenza. Among NA inhibitors,... 
Laninamivir | Oseltamivir | Treatment | Mouse | Influenza virus | Inflamed stage | MORTALITY | INFECTIOUS DISEASES | POSTEXPOSURE PROPHYLAXIS | HUMANS | PATHOGENESIS | PRODRUG | DOUBLE-BLIND | CS-8958 | PHARMACOLOGY & PHARMACY | ACTING NEURAMINIDASE INHIBITOR
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2014, Volume 59, Issue suppl_5, pp. S344 - S351
Journal Article
13.